Help! Please Register
app iq option
  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: Education & Tools >
Astellas Pharma Inc.

conference highlightsConference Highlights

Focus on Fungal Infections 14


Antifungal Combinations
  1. ANTIPROLIFERATIVE ACTIVITY OF HYDRAZONES AND AJOENE ON ISOLATES OF C. NEOFORMANS. SYNERGIC EFFECTS
    Alvarado P1, Vivas J1, Ruiz E1, Ledezma E2, Apiz-Castro R3
    1Laboratory of Parasites Physics and Chemistry, Cellular Biology Center. Institute of Experimental Biology (IBE). Faculty of Sciences, Central University of Venezuela, Caracas (UCV).
    2Faculty of Medicine UDO.
    3Biophysics and Biochemistry Center -IVIC


  2. Safety and Tolerability of Combination Anidulafungin (ANID) and Liposomal Amphotericin B (LAmB) for the Treatment of Invasive Aspergillosis (IA)
    Herbrecht R1, Graham D2, Schuster M3, Henkel T4, Krause D4, Schranz J4, Garbino J5, Caillot D 6, Reinhardt J7, Maertens J8 1Department d'Hematologie et d'Oncologie, Hopital de Hautepierre, Strasbourg, France
    2Springfield Clinic Research, Springfield, USA
    3University of Pennsylvania, Philadelphia, USA
    4Vicuron Pharmaceuticals, King of Prussia, USA
    5Geneva University Hospital, Geneva, USA
    6Haematologique Clinique, Hopital Bocage, Dijon, France
    7Christiana Care Health Services, Newark, USA
    8University Hospital, Leuven, Belgium


  3. IN VITRO INTERACTION OF POSACONAZOLE (POS) AND CASPOFUNGIN (CSP) AGAINST CANDIDA GLABRATA
    Oliveira ER, Fothergill AW, Kirkpatrick WR, Coco BJ, Rinaldi MG, Patterson TF, Redding SW
    University of Texas Health Science Center at San Antonio, USA


top of page    




View other categories
Antifungal Agents | Antifungal Combinations | Antifungal Susceptibility | Basic Mycology
Case Reports | Clinical Mycology | Animal Models | Diagnostics | View All





  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif